IBDEI0QI ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11927,1,2,0)
;;=2^J2182
;;^UTILITY(U,$J,358.3,11927,1,3,0)
;;=3^MEPOLIZUMAB 1MG
;;^UTILITY(U,$J,358.3,11928,0)
;;=J1568^^48^580^81^^^^1
;;^UTILITY(U,$J,358.3,11928,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11928,1,2,0)
;;=2^J1568
;;^UTILITY(U,$J,358.3,11928,1,3,0)
;;=3^OCTAGAM 500MG
;;^UTILITY(U,$J,358.3,11929,0)
;;=J3357^^48^580^107^^^^1
;;^UTILITY(U,$J,358.3,11929,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11929,1,2,0)
;;=2^J3357
;;^UTILITY(U,$J,358.3,11929,1,3,0)
;;=3^USTEKINUMAB 1MG
;;^UTILITY(U,$J,358.3,11930,0)
;;=J9030^^48^580^18^^^^1
;;^UTILITY(U,$J,358.3,11930,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11930,1,2,0)
;;=2^J9030
;;^UTILITY(U,$J,358.3,11930,1,3,0)
;;=3^BCG LIVE INTRAVESICAL INSTILLATION,1MG
;;^UTILITY(U,$J,358.3,11931,0)
;;=J0897^^48^580^30^^^^1
;;^UTILITY(U,$J,358.3,11931,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11931,1,2,0)
;;=2^J0897
;;^UTILITY(U,$J,358.3,11931,1,3,0)
;;=3^DENOSUMAB 1MG (Prolia)
;;^UTILITY(U,$J,358.3,11932,0)
;;=J0400^^48^580^12^^^^1
;;^UTILITY(U,$J,358.3,11932,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11932,1,2,0)
;;=2^J0400
;;^UTILITY(U,$J,358.3,11932,1,3,0)
;;=3^ARIPIPRAZOLE 0.25MG
;;^UTILITY(U,$J,358.3,11933,0)
;;=J0401^^48^580^14^^^^1
;;^UTILITY(U,$J,358.3,11933,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11933,1,2,0)
;;=2^J0401
;;^UTILITY(U,$J,358.3,11933,1,3,0)
;;=3^ARIPIPRAZOLE,EXT RELEASE,1MG
;;^UTILITY(U,$J,358.3,11934,0)
;;=J1944^^48^580^13^^^^1
;;^UTILITY(U,$J,358.3,11934,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11934,1,2,0)
;;=2^J1944
;;^UTILITY(U,$J,358.3,11934,1,3,0)
;;=3^ARIPIPRAZOLE LAUROXIL 1MG
;;^UTILITY(U,$J,358.3,11935,0)
;;=Q0245^^48^580^17^^^^1
;;^UTILITY(U,$J,358.3,11935,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11935,1,2,0)
;;=2^Q0245
;;^UTILITY(U,$J,358.3,11935,1,3,0)
;;=3^BAMLIANIVIMAB/ETESEVIMA 2100MG
;;^UTILITY(U,$J,358.3,11936,0)
;;=J0485^^48^580^16^^^^1
;;^UTILITY(U,$J,358.3,11936,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11936,1,2,0)
;;=2^J0485
;;^UTILITY(U,$J,358.3,11936,1,3,0)
;;=3^BALATACEPT 1MG
;;^UTILITY(U,$J,358.3,11937,0)
;;=Q5104^^48^580^53^^^^1
;;^UTILITY(U,$J,358.3,11937,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11937,1,2,0)
;;=2^Q5104
;;^UTILITY(U,$J,358.3,11937,1,3,0)
;;=3^INFLEXIMAB-ABDA RENIFLEXIS 100MG
;;^UTILITY(U,$J,358.3,11938,0)
;;=Q0139^^48^580^58^^^^1
;;^UTILITY(U,$J,358.3,11938,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11938,1,2,0)
;;=2^Q0139
;;^UTILITY(U,$J,358.3,11938,1,3,0)
;;=3^IRON FERUMOXYTOL 1MG
;;^UTILITY(U,$J,358.3,11939,0)
;;=J9312^^48^580^98^^^^1
;;^UTILITY(U,$J,358.3,11939,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11939,1,2,0)
;;=2^J9312
;;^UTILITY(U,$J,358.3,11939,1,3,0)
;;=3^RITUXIMAB 10MG
;;^UTILITY(U,$J,358.3,11940,0)
;;=J3241^^48^580^102^^^^1
;;^UTILITY(U,$J,358.3,11940,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11940,1,2,0)
;;=2^J3241
;;^UTILITY(U,$J,358.3,11940,1,3,0)
;;=3^TEPROTUMUMAB-TRBW 10MG
;;^UTILITY(U,$J,358.3,11941,0)
;;=86580^^48^581^12^^^^1
;;^UTILITY(U,$J,358.3,11941,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11941,1,2,0)
;;=2^86580
;;^UTILITY(U,$J,358.3,11941,1,3,0)
;;=3^TB INTRADERMAL TEST
;;^UTILITY(U,$J,358.3,11942,0)
;;=82948^^48^581^5^^^^1
;;^UTILITY(U,$J,358.3,11942,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11942,1,2,0)
;;=2^82948
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QI 3768 printed Sep 23, 2025@19:29:47 Page 2
IBDEI0QI ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11927,1,2,0)
+2 ;;=2^J2182
+3 ;;^UTILITY(U,$J,358.3,11927,1,3,0)
+4 ;;=3^MEPOLIZUMAB 1MG
+5 ;;^UTILITY(U,$J,358.3,11928,0)
+6 ;;=J1568^^48^580^81^^^^1
+7 ;;^UTILITY(U,$J,358.3,11928,1,0)
+8 ;;=^358.31IA^3^2
+9 ;;^UTILITY(U,$J,358.3,11928,1,2,0)
+10 ;;=2^J1568
+11 ;;^UTILITY(U,$J,358.3,11928,1,3,0)
+12 ;;=3^OCTAGAM 500MG
+13 ;;^UTILITY(U,$J,358.3,11929,0)
+14 ;;=J3357^^48^580^107^^^^1
+15 ;;^UTILITY(U,$J,358.3,11929,1,0)
+16 ;;=^358.31IA^3^2
+17 ;;^UTILITY(U,$J,358.3,11929,1,2,0)
+18 ;;=2^J3357
+19 ;;^UTILITY(U,$J,358.3,11929,1,3,0)
+20 ;;=3^USTEKINUMAB 1MG
+21 ;;^UTILITY(U,$J,358.3,11930,0)
+22 ;;=J9030^^48^580^18^^^^1
+23 ;;^UTILITY(U,$J,358.3,11930,1,0)
+24 ;;=^358.31IA^3^2
+25 ;;^UTILITY(U,$J,358.3,11930,1,2,0)
+26 ;;=2^J9030
+27 ;;^UTILITY(U,$J,358.3,11930,1,3,0)
+28 ;;=3^BCG LIVE INTRAVESICAL INSTILLATION,1MG
+29 ;;^UTILITY(U,$J,358.3,11931,0)
+30 ;;=J0897^^48^580^30^^^^1
+31 ;;^UTILITY(U,$J,358.3,11931,1,0)
+32 ;;=^358.31IA^3^2
+33 ;;^UTILITY(U,$J,358.3,11931,1,2,0)
+34 ;;=2^J0897
+35 ;;^UTILITY(U,$J,358.3,11931,1,3,0)
+36 ;;=3^DENOSUMAB 1MG (Prolia)
+37 ;;^UTILITY(U,$J,358.3,11932,0)
+38 ;;=J0400^^48^580^12^^^^1
+39 ;;^UTILITY(U,$J,358.3,11932,1,0)
+40 ;;=^358.31IA^3^2
+41 ;;^UTILITY(U,$J,358.3,11932,1,2,0)
+42 ;;=2^J0400
+43 ;;^UTILITY(U,$J,358.3,11932,1,3,0)
+44 ;;=3^ARIPIPRAZOLE 0.25MG
+45 ;;^UTILITY(U,$J,358.3,11933,0)
+46 ;;=J0401^^48^580^14^^^^1
+47 ;;^UTILITY(U,$J,358.3,11933,1,0)
+48 ;;=^358.31IA^3^2
+49 ;;^UTILITY(U,$J,358.3,11933,1,2,0)
+50 ;;=2^J0401
+51 ;;^UTILITY(U,$J,358.3,11933,1,3,0)
+52 ;;=3^ARIPIPRAZOLE,EXT RELEASE,1MG
+53 ;;^UTILITY(U,$J,358.3,11934,0)
+54 ;;=J1944^^48^580^13^^^^1
+55 ;;^UTILITY(U,$J,358.3,11934,1,0)
+56 ;;=^358.31IA^3^2
+57 ;;^UTILITY(U,$J,358.3,11934,1,2,0)
+58 ;;=2^J1944
+59 ;;^UTILITY(U,$J,358.3,11934,1,3,0)
+60 ;;=3^ARIPIPRAZOLE LAUROXIL 1MG
+61 ;;^UTILITY(U,$J,358.3,11935,0)
+62 ;;=Q0245^^48^580^17^^^^1
+63 ;;^UTILITY(U,$J,358.3,11935,1,0)
+64 ;;=^358.31IA^3^2
+65 ;;^UTILITY(U,$J,358.3,11935,1,2,0)
+66 ;;=2^Q0245
+67 ;;^UTILITY(U,$J,358.3,11935,1,3,0)
+68 ;;=3^BAMLIANIVIMAB/ETESEVIMA 2100MG
+69 ;;^UTILITY(U,$J,358.3,11936,0)
+70 ;;=J0485^^48^580^16^^^^1
+71 ;;^UTILITY(U,$J,358.3,11936,1,0)
+72 ;;=^358.31IA^3^2
+73 ;;^UTILITY(U,$J,358.3,11936,1,2,0)
+74 ;;=2^J0485
+75 ;;^UTILITY(U,$J,358.3,11936,1,3,0)
+76 ;;=3^BALATACEPT 1MG
+77 ;;^UTILITY(U,$J,358.3,11937,0)
+78 ;;=Q5104^^48^580^53^^^^1
+79 ;;^UTILITY(U,$J,358.3,11937,1,0)
+80 ;;=^358.31IA^3^2
+81 ;;^UTILITY(U,$J,358.3,11937,1,2,0)
+82 ;;=2^Q5104
+83 ;;^UTILITY(U,$J,358.3,11937,1,3,0)
+84 ;;=3^INFLEXIMAB-ABDA RENIFLEXIS 100MG
+85 ;;^UTILITY(U,$J,358.3,11938,0)
+86 ;;=Q0139^^48^580^58^^^^1
+87 ;;^UTILITY(U,$J,358.3,11938,1,0)
+88 ;;=^358.31IA^3^2
+89 ;;^UTILITY(U,$J,358.3,11938,1,2,0)
+90 ;;=2^Q0139
+91 ;;^UTILITY(U,$J,358.3,11938,1,3,0)
+92 ;;=3^IRON FERUMOXYTOL 1MG
+93 ;;^UTILITY(U,$J,358.3,11939,0)
+94 ;;=J9312^^48^580^98^^^^1
+95 ;;^UTILITY(U,$J,358.3,11939,1,0)
+96 ;;=^358.31IA^3^2
+97 ;;^UTILITY(U,$J,358.3,11939,1,2,0)
+98 ;;=2^J9312
+99 ;;^UTILITY(U,$J,358.3,11939,1,3,0)
+100 ;;=3^RITUXIMAB 10MG
+101 ;;^UTILITY(U,$J,358.3,11940,0)
+102 ;;=J3241^^48^580^102^^^^1
+103 ;;^UTILITY(U,$J,358.3,11940,1,0)
+104 ;;=^358.31IA^3^2
+105 ;;^UTILITY(U,$J,358.3,11940,1,2,0)
+106 ;;=2^J3241
+107 ;;^UTILITY(U,$J,358.3,11940,1,3,0)
+108 ;;=3^TEPROTUMUMAB-TRBW 10MG
+109 ;;^UTILITY(U,$J,358.3,11941,0)
+110 ;;=86580^^48^581^12^^^^1
+111 ;;^UTILITY(U,$J,358.3,11941,1,0)
+112 ;;=^358.31IA^3^2
+113 ;;^UTILITY(U,$J,358.3,11941,1,2,0)
+114 ;;=2^86580
+115 ;;^UTILITY(U,$J,358.3,11941,1,3,0)
+116 ;;=3^TB INTRADERMAL TEST
+117 ;;^UTILITY(U,$J,358.3,11942,0)
+118 ;;=82948^^48^581^5^^^^1
+119 ;;^UTILITY(U,$J,358.3,11942,1,0)
+120 ;;=^358.31IA^3^2
+121 ;;^UTILITY(U,$J,358.3,11942,1,2,0)
+122 ;;=2^82948
